新股孖展统计 | 9月26日

Group 1 - Changfeng Pharmaceutical (02652) is currently in the process of an IPO, with a total of HKD 968.97 million borrowed from brokers including Futu, Huatai, and Xincheng as of September 26 [1][2] - The IPO has been oversubscribed by more than 14.8 times, indicating strong investor interest [1][2] - The total fundraising amount for Changfeng Pharmaceutical is reported to be HKD 61 million [2]